DRKS00027990
Suspended
Not Applicable
Registry for children, adolescents and adults with Osteosarcoma and biologically related bone sarcomas (COSS-Registry) - COSS-Registry
Klinikum der Landeshauptstadt Stuttgart gKAöRZentrum für Kinder-, Jugend- und Frauenmedizin Standort Mitte (Olgahospital) Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)Cooperative Osteosarkom Studiengruppe (COSS)0 sites1,000 target enrollmentFebruary 15, 2022
ConditionsMalignant high-grade osteosarcoma subtypes (conventional: osteoblastic, chondroblastic, fibroblastic, giant cell rich, osteoblastom-like, epithelioid, clear cell, chondroblastom-likenon-conventional: telangiectatic, small cell, high-grade surface), periosteal, parosteal, extra-skeletal, low-grade central, undifferentiated pleomorphic sarcoma, osseous leiomysarcoma, osseous dedifferentiated chondrosarcoma, osseous mesenchymal chondrosarcoma, osseous fibrosarcoma, osseous angiosarcoma
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Malignant high-grade osteosarcoma subtypes (conventional: osteoblastic, chondroblastic, fibroblastic, giant cell rich, osteoblastom-like, epithelioid, clear cell, chondroblastom-like
- Sponsor
- Klinikum der Landeshauptstadt Stuttgart gKAöRZentrum für Kinder-, Jugend- und Frauenmedizin Standort Mitte (Olgahospital) Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)Cooperative Osteosarkom Studiengruppe (COSS)
- Enrollment
- 1000
- Status
- Suspended
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients regardless of gender, age, tumor stage, current or future clinical trial participation with histologically proven diagnosis of one of the following tumors: Malignant high\-grade osteosarcoma subtypes (conventional: osteoblastic, chondroblastic, fibroblastic, giant cell rich, osteoblastom\-like, epithelioid, clear cell, chondroblastom\-like; non\-conventional: telangiectatic, small cell, high\-grade surface), periosteal, parosteal, extra\-skeletal, low\-grade central, undifferentiated pleomorphic sarcoma, osseous leiomysarcoma, osseous dedifferentiated chondrosarcoma, osseous mesenchymal chondrosarcoma, osseous fibrosarcoma, osseous angiosarcoma
- •\- Obtained informed consent of the patient and/or his/her legal guardian(s)
Exclusion Criteria
- •\- No information and informed consent of the patient and/or the legal guardian
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Registry for neonates, infants, children, adolescents,and adults with newly diagnosed and/or relapsedneuroblastic tumors(NB Registry 2016)C74.1Medulla of adrenal glandDRKS00023442K Köln5,000
Not yet recruiting
Not Applicable
utritional Status of children and adolescents with cerebral palsy while participating in back on your feet-conceptG80.0Spastic quadriplegic cerebral palsyDRKS00010292niklinik Köln100
Active, not recruiting
Phase 1
A long-term study to follow patients infected with chronic Hepatitis C who received a Gilead Hepatitis C treatment in a Gilead clinical trialEUCTR2014-004674-42-BEGilead Sciences, Inc.300
Active, not recruiting
Phase 1
A long-term study to follow patients infected with chronic Hepatitis C who received a Gilead Hepatitis C treatment in a Gilead clinical trialEUCTR2014-004674-42-GBGilead Sciences, Inc.560
Active, not recruiting
Phase 1
A long-term study to follow patients infected with chronic Hepatitis C who received a Gilead Hepatitis C treatment in a Gilead clinical trialEUCTR2014-004674-42-PLGilead Sciences, Inc560